Lenacapavir by Gilead demonstrates 96% reduction in HIV infections in clinical trial.

A recent study has shown that Gilead’s new HIV prevention injectable drug, lenacapavir, has proven to reduce HIV infections by 96%. This positive phase-three trial data indicates the potential approval

Detail

Kamala Harris Surging in Polls Leads to Increased Wealth Transfers to Children

The close presidential race has sparked a surge in tax planning among ultra-wealthy investors, particularly due to concerns about a potential increase in estate taxes. The looming expiration of a

Detail